Methods A retrospective chart review was performed by a pharmacist team to determine the
daily dose of citalopram for all adult patients with an active prescription. Patients were …

Objectives In 2011, the US Food and Drug Administration (FDA) issued a safety
announcement cautioning providers against prescribing citalopram above 40 mg per day …

Objectives To evaluate national trends in electrocardiogram (EKG) monitoring in Veterans
Affairs (VA) beneficiaries prescribed high‐dose citalopram before and after the 2011–12 …

Objective In 2011–2012 the US Food and Drug Administration (FDA) issued safety
announcements cautioning providers against prescribing high doses of citalopram given …

Objective: A public safety communication issued by the Food and Drug Administration
declared that citalopram dosages exceeding 40 mg/day were no longer considered safe …

Recently, Forest Laboratories warned about QTc prolongation associated with the use of
citalopram. After these reports, the FDA warned that citalopram should no longer be used at …

Background: Citalopram and escitalopram are commonly used serotonin-specific reuptake
inhibitors (SSRIs) for the treatment of depression and anxiety; which are known to cause …

Objective: The US Food and Drug Administration (FDA) issued a warning stating that
patients older than 60 years are not recommended to receive doses of citalopram exceeding …

Introduction Neuropsychiatric disorders affect millions of older adults. Despite this, there are
relatively few older adults included in clinical trials evaluating treatments for psychiatric …

Introduction: Neuropsychiatric disorders affect millions of older adults. Despite this, there are
relatively few older adults included in clinical trials evaluating treatments for psychiatric …